Clinical Trials Logo

Clinical Trial Summary

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02864446
Study type Observational
Source Seoul National University Hospital
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06048614 - Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis. N/A
Completed NCT03513640 - Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants